Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
9.97
+0.05 (0.50%)
Nov 20, 2024, 4:00 PM EST - Market closed
Theravance Biopharma Employees
Theravance Biopharma had 99 employees as of December 31, 2023. The number of employees decreased by 12 or -10.81% compared to the previous year.
Employees
99
Change (1Y)
-12
Growth (1Y)
-10.81%
Revenue / Employee
$638,303
Profits / Employee
-$499,000
Market Cap
490.27M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
GRAIL | 1,360 |
Treace Medical Concepts | 516 |
REGENXBIO | 344 |
Esperion Therapeutics | 240 |
Arcturus Therapeutics Holdings | 180 |
Y-mAbs Therapeutics | 100 |
PureTech Health | 90 |
Olema Pharmaceuticals | 74 |
TBPH News
- 1 day ago - Theravance Biopharma to Participate in an Upcoming Investor Conference - PRNewsWire
- 8 days ago - Theravance Biopharma, Inc. (TBPH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value - PRNewsWire
- 4 weeks ago - Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024 - PRNewsWire
- 4 weeks ago - Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease - PRNewsWire
- 3 months ago - Theravance Biopharma, Inc. (TBPH) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Theravance Biopharma, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update - PRNewsWire
- 4 months ago - Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024 - PRNewsWire